VERU INC. Operating Lease, Liability, Noncurrent
VERU INC. (VERU) had Operating Lease, Liability, Noncurrent of $1.91 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-10
- 2026-06-30: Operating Lease, Liability, Noncurrent $1.91M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $2.06M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $2.21M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $2.36M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $1.91M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $2.06M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $2.21M 10-Q · filed 2026-02-11 | |
| 2025-09-30 | $2.36M 10-Q · filed 2026-08-10 | |
| 2025-06-30 | $2.50M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $2.64M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.78M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $2.91M 10-K · filed 2025-12-17 | $2.92M 10-K · filed 2024-12-16 |
| 2024-06-30 | $3.07M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $3.26M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $3.46M 10-Q · filed 2024-04-01 | |
| 2023-09-30 | $3.63M 10-K · filed 2024-12-16 | |
| 2023-06-30 | $3.81M 10-Q/A · filed 2023-11-15 | |
| 2023-03-31 | $3.99M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $3.96M 10-Q · filed 2023-02-09 | |
| 2022-09-30 | $4.09M 10-K/A · filed 2024-04-01 | |
| 2022-06-30 | $4.26M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $4.45M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $522.71K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $609.92K 10-K · filed 2022-12-05 | |
| 2021-06-30 | $702.99K 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $786.35K 10-Q · filed 2021-05-12 | |
| 2020-12-31 | $899.12K 10-Q · filed 2021-02-10 | |
| 2020-09-30 | $990.02K 10-K · filed 2021-12-02 | |
| 2020-06-30 | $808.40K 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $871.57K 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $970.38K 10-Q · filed 2020-02-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |